ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
George Hicks
Richard A. DeWall
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zwart, H. H. J.
Right arrow Articles by DeWall, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zwart, H. H. J.
Right arrow Articles by DeWall, R. A.

Ann Thorac Surg 1979;28:158-165
© 1979 The Society of Thoracic Surgeons

Articles

Clinical Experience with the Lillehei-Kaster Valve Prosthesis

Hans H.J. Zwart, M.D.*, George Hicks, M.D., Benjamin Schuster, M.D., Milton Nathan, M.D., Farouk Tabrah, M.D., Frank Wenzke, M.D., Tajuddin Ahmed, M.D., Richard A. DeWall, M.D.

From the Divisions of Cardiothoracic Surgery and Cardiology, Kettering Medical Center and Wright State University Medical School, Dayton, OH

* Address reprint requests to Dr. Zwart, 111 W First St, Suite 910, Dayton, OH 45402

The Lillehei-Kaster valve was used in 215 patients over a 7-year period. The aortic valve was replaced in 81 of them. Hospital mortality was 21% (17 patients). Ten patients were lost to follow-up and long-term mortality was 5% (3 patients). The incidence of thromboembolism was 2.6 per 100 patient-years, and actuarial survival was 96% at 5 and 87% at 7 years. Mitral valve replacement was performed in 108 patients. Hospital mortality was 20% (22 patients), 24 patients were lost to follow-up, and long-term mortality was 13% (11 patients). The combined incidence of thromboembolism was 5.0 per 100 patient-years, and actuarial survival was 81% at 5 years and 75% at 7 years. In both groups, the majority of patients improved clinically. Fifteen patients had double-valve replacement, and 11 had coronary revascularization in addition to valve replacement.




This article has been cited by other articles:


Home page
 JAMAHome page
M. H. Eckman, J. R. Beshansky, I. Durand-Zaleski, H. J. Levine, and S. G. Pauker
Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves: Does Low Risk Mean High Cost?
JAMA, March 16, 1990; 263(11): 1513 - 1521.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. A. Abdulali, N. P. Silverton, F. J. Schoen, N. R. Saunders, and M. I. Ionescu
Late Outcome of Patients with Braunwald-Cutter Mitral Valve Replacement
Ann. Thorac. Surg., December 1, 1984; 38(6): 579 - 585.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. T. Janusz, W. R. E. Jamieson, P. Allen, A. I. Munro, R. T. Miyagishima, H. Tutassura, L. H. Burr, A. N. Gerein, and G. F. O. Tyers
Experience with the Carpentier-Edwards Porcine Valve Prosthesis in 700 Patients
Ann. Thorac. Surg., December 1, 1982; 34(6): 625 - 633.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. H. Edmunds Jr.
Thromboembolic Complications of Current Cardiac Valvular Prostheses
Ann. Thorac. Surg., July 1, 1982; 34(1): 96 - 106.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. Lepley Jr., R. J. Flemma, D. C. Mullen, M. Motl, A. J. Anderson, and E. Weirauch
Long-Term Follow-up of the Bjork-Shiley Prosthetic Valve Used in the Mitral Position
Ann. Thorac. Surg., August 1, 1980; 30(2): 164 - 172.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1979 by The Society of Thoracic Surgeons.